January 9, 2023 Meeting Of The Dermatologic And Ophthalmic Drugs Advisory Committee

January 9, 2023 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)

U.S. Food and Drug Administration

January 24, 2023 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

U.S. Food and Drug Administration

March 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

March 16, 2023 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

U.S. Food and Drug Administration

Oncologic Drugs Advisory Committee Meeting

U.S. Food and Drug Administration

September 21, 2023 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)

U.S. Food and Drug Administration

June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)

U.S. Food and Drug Administration

December 13, 2022 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

U.S. Food and Drug Administration

May 11, 2023 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

U.S. Food and Drug Administration

Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

September 13, 2023 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

U.S. Food and Drug Administration

November 9, 2022 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

U.S. Food and Drug Administration

June 28, 2023 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)

U.S. Food and Drug Administration

April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting

U.S. Food and Drug Administration

May 19, 2023 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)

U.S. Food and Drug Administration

AARS Member Highlight Interview: Dr. John Barbieri discusses iPLEDGE

American Acne and Rosacea Society

March 14, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

September 7, 2022 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee

U.S. Food and Drug Administration